Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: $37.48 Billion USD

As of October 2024 Alnylam Pharmaceuticals has a market cap of $37.48 Billion USD. This makes Alnylam Pharmaceuticals the world's 556th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 21st, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

$37.48 Billion USD

by Yahoo Finance

$37.48 Billion USD

by CompaniesMarketCap

$37.44 Billion USD

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Arrowhead Pharmaceuticals ARWR	$2.54 B	-93.21%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	$106.76 B	184.79%	🇺🇸 USA
Sarepta Therapeutics SRPT	$12.14 B	-67.61%	🇺🇸 USA
OPKO Health OPK	$1.00 B	-97.32%	🇺🇸 USA
Regulus Therapeutics RGLS	$98.19 M	-99.74%	🇺🇸 USA
Novartis NVS	$235.07 B	527.05%	🇨🇭 Switzerland
Sanofi SNY	$136.85 B	265.07%	🇫🇷 France
Teva Pharmaceutical Industries TEVA	$20.81 B	-44.48%	🇮🇱 Israel